Viewing Study NCT01165502


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-07-14 @ 9:51 PM
Study NCT ID: NCT01165502
Status: COMPLETED
Last Update Posted: 2011-01-19
First Post: 2010-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers
Sponsor: CellMed AG, a subsidiary of BTG plc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MAD study CM3.1-AC100 View
None Healthy men, age 18 - 50 View